Fig. 1From: Comparative study of the inhibitory effect on bone erosion progression with denosumab treatment and conventional treatment in rheumatoid arthritis patients: study protocol for an open-label randomized controlled trial by HR-pQCTStudy design. Abbreviation: csDMARD conventional synthetic disease-modifying anti-rheumatic drug.Back to article page